Kingworld Medicines Group Limited

SEHK:1110 Voorraadrapport

Marktkapitalisatie: HK$255.0m

Kingworld Medicines Group Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Kingworld Medicines Group is de winst gegroeid met een gemiddeld jaarlijks percentage van 0.5%, terwijl de Healthcare industrie de winst jaarlijks groeide met 11.8%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 4.2% per jaar. Het rendement op eigen vermogen van Kingworld Medicines Group is 7.9%, en het heeft een nettomarge van 3%.

Belangrijke informatie

0.5%

Groei van de winst

1.7%

Groei van de winst per aandeel

Healthcare Groei van de industrie11.3%
Inkomstengroei4.2%
Rendement op eigen vermogen7.9%
Nettomarge3.0%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Recent updates

The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Nov 13
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17
Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11
The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07
Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05
Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17
We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29
Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08
Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15
Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25
Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

Dec 18
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

Dec 05
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Nov 22
What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Opbrengsten en kosten

Hoe Kingworld Medicines Group geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SEHK:1110 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 241,052312120
31 Mar 241,065352170
31 Dec 231,079382230
30 Sep 231,085372180
30 Jun 231,091362130
31 Mar 231,024292100
31 Dec 22958232060
30 Sep 22905292030
30 Jun 22852352000
31 Mar 22850331980
31 Dec 21847301960
30 Sep 21858262220
30 Jun 21868212480
31 Mar 21807172470
31 Dec 20745122460
30 Sep 20749162270
30 Jun 20752202080
31 Mar 20865322140
31 Dec 19978432200
30 Sep 191,010452210
30 Jun 191,041462220
31 Mar 191,060442370
31 Dec 181,079412520
30 Sep 181,079492640
30 Jun 181,079562770
31 Mar 181,055542640
31 Dec 171,031512510
30 Sep 171,088502400
30 Jun 171,145492290
31 Mar 171,099482270
31 Dec 161,054472250
30 Sep 16909412090
30 Jun 16764351930
31 Mar 16739341820
31 Dec 15714321710
30 Sep 15711341630
30 Jun 15708361550
31 Mar 15684371440
31 Dec 14660381340
30 Sep 14640431260
30 Jun 14619481190
31 Mar 14587481150
31 Dec 13555471120

Kwaliteitswinsten: 1110 heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (3%) 1110 } zijn lager dan vorig jaar (3.3%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van 1110 is de afgelopen 5 jaar met 0.5% per jaar gegroeid.

Versnelling van de groei: De winstgroei 1110 is het afgelopen jaar negatief geweest en kan daarom niet worden vergeleken met het 5-jarig gemiddelde.

Winst versus industrie: 1110 had het afgelopen jaar een negatieve winstgroei ( -14.3% ), waardoor het moeilijk is om te vergelijken met het branchegemiddelde Healthcare ( -16.9% ).


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 7.9% ) van 1110 wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden